Clinical Trial Update: Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing Leukine (sargramostim) and Neupogen (filgrastim) in patients with bladder/urothelial cancer receiving cisplatin and gemci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Leukine (sargramostim)
• Neupogen (Filgrastim)

Snippet

Sponsor: University of Kentucky | Conditions: Bladder Cancer | Phase 3 | Status: TERMINATED